Literature DB >> 10215174

A procedure for generating bootstrap samples for the validation of nonlinear mixed-effects population models.

J Parke1, N H Holford, B G Charles.   

Abstract

A method is presented for automated preparation of bootstrap data samples and their presentation to NONMEM for use in the validation of population pharmacokinetic or pharmacodynamic models, which have been developed with relatively small numbers of subjects. The bootstrap sampling procedure involves the use of an MS-DOS batch file and a script file for use with the public-domain text processing program, AWK, which is a single EXE file (48k in size for the version used in this report). A UNIX version of AWK is also available and UNIX users can adapt the process to their needs. Its use obviates the need for expensive, high-end statistical packages and associated script files written using in-built programming languages. The method can easily be adapted to bootstrap sampling requirements in other biomedical modelling applications.

Mesh:

Year:  1999        PMID: 10215174     DOI: 10.1016/s0169-2607(98)00098-4

Source DB:  PubMed          Journal:  Comput Methods Programs Biomed        ISSN: 0169-2607            Impact factor:   5.428


  127 in total

1.  Population pharmacokinetics of fluconazole in critically ill patients receiving continuous venovenous hemodiafiltration: using Monte Carlo simulations to predict doses for specified pharmacodynamic targets.

Authors:  Kashyap Patel; Jason A Roberts; Jeffrey Lipman; Susan E Tett; Megan E Deldot; Carl M Kirkpatrick
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

2.  Population pharmacokinetic analysis of risperidone and 9-hydroxyrisperidone with genetic polymorphisms of CYP2D6 and ABCB1.

Authors:  Hee-Doo Yoo; Hea-Young Cho; Sang-No Lee; Hwa Yoon; Yong-Bok Lee
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-05-24       Impact factor: 2.745

3.  Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury.

Authors:  Jason A Roberts; Jonathan Field; Adam Visser; Rosemary Whitbread; Mandy Tallot; Jeffrey Lipman; Carl M J Kirkpatrick
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

4.  Impact of aminophylline on the pharmacodynamics of propofol in beagle dogs.

Authors:  Soo-Han Lee; Hyun-Ji Kang; Seok-Joon Jin; Do-Yang Park; Yoon-Ji Choi; Byung-Moon Choi; Eun-Kyung Lee; Gyu-Jeong Noh
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-08-24       Impact factor: 2.745

5.  Population pharmacokinetics and dose simulation of carvedilol in paediatric patients with congestive heart failure.

Authors:  Stefanie Albers; Bernd Meibohm; Thomas S Mir; Stephanie Läer
Journal:  Br J Clin Pharmacol       Date:  2007-11-08       Impact factor: 4.335

6.  Population pharmacokinetics of intravenous pantoprazole in paediatric intensive care patients.

Authors:  Géraldine Pettersen; Mohamad-Samer Mouksassi; Yves Théorêt; Line Labbé; Christophe Faure; Bao Nguyen; Catherine Litalien
Journal:  Br J Clin Pharmacol       Date:  2008-10-23       Impact factor: 4.335

7.  Race/Ethnicity and Protease Inhibitor Use Influence Plasma Tenofovir Exposure in Adults Living with HIV-1 in AIDS Clinical Trials Group Study A5202.

Authors:  Cindy J Bednasz; Charles S Venuto; Qing Ma; Eric S Daar; Paul E Sax; Margaret A Fischl; Ann C Collier; Kimberly Y Smith; Camlin Tierney; Edward P Acosta; Donald E Mager; Gene D Morse
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

8.  Busulfan in infant to adult hematopoietic cell transplant recipients: a population pharmacokinetic model for initial and Bayesian dose personalization.

Authors:  Jeannine S McCune; Meagan J Bemer; Jeffrey S Barrett; K Scott Baker; Alan S Gamis; Nicholas H G Holford
Journal:  Clin Cancer Res       Date:  2013-11-11       Impact factor: 12.531

9.  Semi-mechanistic population pharmacokinetic drug-drug interaction modelling of a long half-life substrate and itraconazole.

Authors:  Thorsten Lehr; Alexander Staab; Dirk Trommeshauser; Hans Guenter Schaefer; Charlotte Kloft
Journal:  Clin Pharmacokinet       Date:  2010       Impact factor: 6.447

10.  Urinary coproporphyrin I/(I + III) ratio as a surrogate for MRP2 or other transporter activities involved in methotrexate clearance.

Authors:  Isabelle Benz-de Bretagne; Noël Zahr; Amélie Le Gouge; Jean-Sébastien Hulot; Caroline Houillier; Khe Hoang-Xuan; Emmanuel Gyan; Séverine Lissandre; Sylvain Choquet; Chantal Le Guellec
Journal:  Br J Clin Pharmacol       Date:  2014-08       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.